Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01287013 · ClinicalTrials.gov registry record · NA
Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures
A NA study, sponsored by National Institutes of Health Clinical Center (CC).
- Terminated
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT01287013 is a NA study that was terminated before completion, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 87 participants.
The verdict
NCT01287013, a NA study, was terminated before completion, sponsored by National Institutes of Health Clinical Center (CC).
- TERMINATED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
Background: \- Procedures that use medical tools in or near a possible abnormality in the body often use computed tomography (CT) scans to locate the abnormality and guide the path that a needle will take to collect a sample of tissue. Xperguide and electromagnetic (EM) tracking are two new procedures being studied to help guide the needle. Xperguide is software that uses CT images to help the doctor choose the needle path. EM tracking uses special medical tools with miniature coils that act like a Global Positioning Satellite (GPS) device to show the location of the needle in the body. Xperguide and EM tracking have been used in humans and have good results, but they have not been compared with each other and regular CT to determine whether they are better than the standard approach. Objectives: \- To compare the results of Xperguide, electromagnetic tracking, and regular computed tomography during a guided percutaneous procedure. Eligibility: \- Individuals at least 18 years of age who are required to have a CT-guided percutaneous procedure. Design: * Participants will be screened with a physical examination and medical history, and the results of any previous imaging studies will be examined before study enrollment. * After a pilot phase, the study will involve two phases to compare the results of the different procedures. The first phase will involve comparing Xperguide to CT, and the second will involve comparing Xperguide to EM tracking. * Phase 1 participants will be assigned to one of two procedure groups: Group 1 will have Xperguide, and Group 2 will have regular CT. Participants who are scheduled to have repeated procedures (like a biopsy before and after chemotherapy) will be randomized for the first procedure and the second procedure will be done using the other method. * Phase 2 participants will be assigned to one of two procedure groups: Group 1 will have Xperguide, and Group 2 will have EM tracking. Participants who are scheduled to have repea
Interventions
- DEVICE Cone-beam computed tomography (CT)
- DEVICE Conventional Computed Tomography (CT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2011-01 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01287013
The ClinicalTrials.gov registry entry for NCT01287013 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cone-beam computed tomography (CT) is the first listed.
NCT01287013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01287013 about?
NCT01287013 is a clinical study titled "Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures". Background: \- Procedures that use medical tools in or near a possible abnormality in the body often use computed tomography (CT) scans to locate the abnormality and guide the path that a needle will take to collect a sample of tissue. Xperguide and electromagnetic (EM) tracking are two new procedu...
What is the current status of trial NCT01287013?
This trial is currently terminated. It is a NA study. The enrollment target is 87 participants. The study started on 2011-01. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01287013?
The interventions under investigation include: Cone-beam computed tomography (CT) (DEVICE), Conventional Computed Tomography (CT) (DEVICE).
Who is sponsoring clinical trial NCT01287013?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.